Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?

Research output: Contribution to journalLetterScientific

Original languageEnglish
JournalBritish Journal of Clinical Pharmacology
Volume85
Issue number4
Pages (from-to)859-860
Number of pages2
ISSN0306-5251
DOIs
Publication statusPublished - Apr 2019
MoE publication typeB1 Journal article

Fields of Science

  • HUMAN UDP-GLUCURONOSYLTRANSFERASES
  • CODEINE
  • 317 Pharmacy

Cite this

@article{a24ae9b86ed54fac892ea2b2be4aaf8e,
title = "Case report by Toce and co-authors: Have all the reasons for poor morphine glucuronidation been addressed?",
keywords = "HUMAN UDP-GLUCURONOSYLTRANSFERASES, CODEINE, 317 Pharmacy",
author = "Moshe Finel and Erkka J{\"a}rvinen",
year = "2019",
month = "4",
doi = "10.1111/bcp.13868",
language = "English",
volume = "85",
pages = "859--860",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley",
number = "4",

}

TY - JOUR

T1 - Case report by Toce and co-authors

T2 - Have all the reasons for poor morphine glucuronidation been addressed?

AU - Finel, Moshe

AU - Järvinen, Erkka

PY - 2019/4

Y1 - 2019/4

KW - HUMAN UDP-GLUCURONOSYLTRANSFERASES

KW - CODEINE

KW - 317 Pharmacy

U2 - 10.1111/bcp.13868

DO - 10.1111/bcp.13868

M3 - Letter

VL - 85

SP - 859

EP - 860

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 4

ER -